Nippon India Pharma Fund vs Tata India Pharma & Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Invest NowTata India Pharma & Healthcare Fund-Regular Plan-Growth
Invest NowChart Comparison
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8689 Cr | ₹1208 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 21% | 26.49% |
Expense Ratio | 1.81 | 2.14 |
Manager | Sailesh Raj Bhan | Meeta Shetty |
ISIN Code | INF204K01968 | INF277K016A9 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | -2.59% | -2% |
6 Month | 8.58% | 11.06% |
1 Year | 22.78% | 29.02% |
3 Year | 19.11% | 20.59% |
5 Year | 26.13% | 25.88% |
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | - | - |
1 Year | 14.69% | 19.99% |
3 Year | 27.2% | 29.34% |
5 Year | 22.9% | 23.84% |
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 17.79% | 6.67% |
3 Year | 20.87% | 17.46% |
5 Year | 20.18% | 14.22% |
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 14.36% | 14.23% |
Sharp | 0.78% | 0.74% |
Beta | 0.87% | 0.9% |
Alpha | 1.67% | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts GuidanceScheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Meeta Shetty |
Total AUM | ₹96086 Cr | ₹17847 Cr |
Fund Manage | 5 | 5 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 4.4 | 5.39 |
Large Cap | 45.96 | 40.33 |
Mid Cap | 27.12 | 30.82 |
Small Cap | 22.52 | 23.46 |
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 4.4 | 5.39 |
Pharmaceuticals & Biotechnology | 75.86 | 76.28 |
Healthcare Services | 17.38 | 14.31 |
Retailing | 2.36 | 0.66 |
Fertilizers & Agrochemicals | - | 0.83 |
Chemicals & Petrochemicals | - | 0.39 |
Insurance | - | 2.14 |
Top Comparisons
Nippon India Nifty IT Index Fund - Reg (G)
3Y Returns0%
Tata Digital India Fund-Regular Plan-Growth
3Y Returns10.3%
ICICI Prudential Credit Risk Fund - Growth
3Y Returns6.95%
Baroda BNP Paribas Credit Risk Fund -Regular-Growth Option
3Y Returns6.73%
ICICI Prudential Balanced Advantage Fund - Growth
3Y Returns11.57%
Edelweiss Balanced Advantage Fund - Regular Plan - Growth Option
3Y Returns10.26%
Motilal Oswal Asset Allocation FOF- C- Regular Growth
3Y Returns9.99%
HSBC Managed Solutions - Moderate - Growth
3Y Returns10.27%